Valenz has partnered with MSL Captive Solutions to launch CaptiV, a medical stop-loss group captive programme targeting employers with less than 1,000 employees.
The new programme aims to solve the challenges market volatility can pose for small to medium-sized employers, according to Valenz.
To accelerate its captive offering, Valenz teamed up with MSL Captive Solutions, a platform dedicated to the development and delivery of comprehensive services exclusively for medical stop-loss captives.
Valenz CaptiV leverages a larger and more diverse population to help reduce plan level and catastrophic risk. In addition, it will provide cost-reduction strategies, increased underwriting credibility, and long-term rate stability.
Rob Gelb, CEO of Valenz, says: “We operate at the centre of the medical stop-loss group captive, actively engaging the group of employers and their employees in our proprietary ecosystem of data and service solutions.”
He adds: “Our analytic and predictive capabilities uncover new strategies to drive savings of 20 to 30 per cent by targeting the high-dollar claims that drive the majority of health plan spending. We continually integrate those learnings among Valenz CaptiV members to reduce the potential for catastrophic claims and create value for everyone.”
Phil Giles, managing director of MSL Captive Solutions, notes: “Properly structured group captives have proved to reduce costs and increase plan stability by effectively managing, diversifying and broadly diffusing risk.”
“By taking a discerning approach to membership and enabling more active, data-driven risk management, Valenz CaptiV promises superior performance,” he adds.
